11/4/25 06:16  | 10/31/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 21 | 9.26 | 0 | 2 | 0 | 5,573 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/29/25 06:14  | 4/25/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 36 | 9.88 | 0 | 4 | 0 | 5,571 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/22/25 06:05  | 4/17/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 48 | 8.98 | 0 | 5 | 0 | 5,567 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/8/25 06:05  | 4/7/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 33 | 9.10 | 0 | 4 | 0 | 5,562 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/7/25 07:50  | 4/4/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 48 | 8.73 | 0 | 6 | 0 | 5,558 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/13/25 06:05  | 1/10/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 31 | 12.51 | 0 | 3 | 0 | 5,553 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/8/25 06:10  | 1/6/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P.m | 39 | 13.58 | 0 | 3 | 0 | 5,550 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/7/25 06:05  | 1/3/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 44 | 12.95 | 0 | 3 | 0 | 5,547 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/6/25 06:05  | 1/2/25  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 24 | 11.97 | 0 | 2 | 0 | 5,544 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/25 06:05  | 12/31/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 27 | 11.36 | 0 | 2 | 0 | 5,542 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/2/25 06:05  | 12/30/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 36 | 11.12 | 0 | 3 | 0 | 5,539 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/30/24 06:04  | 9/26/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 22 | 14.63 | 0 | 2 | 0 | 5,536 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/8/24 06:05  | 8/6/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 28 | 13.81 | 0 | 2 | 0 | 5,535 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/7/24 06:05  | 8/5/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 72 | 13.18 | 0 | 6 | 0 | 5,533 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/24/24 06:05  | 7/23/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 24 | 15.89 | 0 | 2 | 0 | 5,527 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/17/24 06:10  | 6/13/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 2,500 | 14.30 | 0 | 175 | 3 | 5,526 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/3/24 06:10  | 4/1/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 57 | 19.08 | 0 | 3 | 0 | 5,351 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/26/24 06:05  | 3/22/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 19.98 | 0 | 3 | 0 | 5,348 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/22/24 06:02  | 3/20/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 27 | 17.68 | 0 | 2 | 0 | 5,345 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/7/24 09:41  | 3/5/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P.a | 44 | 12.49 | 0 | 4 | 0 | 5,344 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/7/24 06:05  | 3/5/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 381 | 12.49 | 0 | 31 | 1 | 5,344 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/6/24 06:05  | 3/4/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 53 | 13.03 | 0 | 4 | 0 | 5,340 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/21/24 06:05  | 2/16/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 121 | 11.16 | 0 | 11 | 0 | 5,336 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/20/24 06:04  | 2/15/24  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 141 | 11.07 | 0 | 13 | 0 | 5,325 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/14/23 06:05  | 11/10/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 51 | 10.17 | 0 | 5 | 0 | 5,313 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/7/23 06:15  | 11/3/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 32 | 9.11 | 0 | 4 | 0 | 5,308 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/30/23 06:15  | 10/26/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 7.97 | 0 | 3 | 0 | 5,304 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/27/23 06:15  | 10/25/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 7.91 | 0 | 3 | 0 | 5,302 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/12/23 06:05  | 10/10/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.07 | 0 | 1 | 0 | 5,299 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/5/23 06:05  | 10/4/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 17 | 8.63 | 0 | 2 | 0 | 5,298 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/21/23 06:05  | 9/19/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 36 | 8.95 | 0 | 4 | 0 | 5,296 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/13/23 06:05  | 9/11/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.48 | 0 | 1 | 0 | 5,292 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/24/23 06:05  | 8/22/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 10 | 9.97 | 0 | 1 | 0 | 5,291 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/8/23 06:05  | 8/4/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 21 | 10.55 | 0 | 2 | 0 | 5,290 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/25/23 06:15  | 7/21/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.20 | 0 | 1 | 0 | 5,288 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/18/23 06:01  | 5/17/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 12 | 11.69 | 0 | 1 | 0 | 5,287 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/21/23 06:05  | 4/19/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 78 | 11.10 | 0 | 7 | 0 | 5,286 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/20/23 06:05  | 4/18/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 22 | 11.12 | 0 | 2 | 0 | 5,279 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/12/23 06:02  | 4/11/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 62 | 12.42 | 0 | 5 | 0 | 5,271 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/13/23 07:15  | 3/10/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 12 | 12.12 | 0 | 1 | 0 | 2,737 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/22/23 06:07  | 2/17/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 10 | 16.53 | 0 | 1 | 0 | 2,736 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/23 06:08  | 2/10/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 19 | 18.68 | 0 | 1 | 0 | 2,736 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/23 06:15  | 1/27/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 39 | 19.35 | 0 | 2 | 0 | 2,735 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/24/23 06:05  | 1/20/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 26 | 17.37 | 0 | 2 | 0 | 2,733 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/10/23 06:05  | 1/6/23  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 23 | 15.18 | 0 | 2 | 0 | 2,731 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/3/23 06:05  | 12/29/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 61 | 15.19 | 0 | 4 | 0 | 2,730 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/20/22 06:05  | 12/16/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 13 | 13.01 | 0 | 1 | 0 | 2,726 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/13/22 06:05  | 12/9/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 26 | 13.11 | 0 | 2 | 0 | 2,725 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/6/22 06:15  | 12/2/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 14 | 13.84 | 0 | 1 | 0 | 2,723 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/4/22 06:15  | 11/2/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 18 | 8.79 | 0 | 2 | 0 | 2,722 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/17/22 07:00  | 10/14/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 29 | 9.75 | 0 | 3 | 0 | 2,720 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/11/22 06:05  | 10/7/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 19 | 9.72 | 0 | 2 | 0 | 2,717 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/4/22 06:05  | 9/30/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.46 | 0 | 1 | 0 | 2,715 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/3/22 06:15  | 9/29/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 9 | 9.23 | 0 | 1 | 0 | 2,714 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/27/22 06:05  | 6/24/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 265 | 9.13 | 0 | 29 | 1 | 5,419 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/17/22 06:05  | 6/16/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 57 | 7.13 | 0 | 8 | 0 | 2,684 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/15/22 06:05  | 6/14/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 95 | 7.91 | 0 | 12 | 0 | 2,676 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/13/22 06:04  | 6/10/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 100 | 8.33 | 0 | 12 | 0 | 2,664 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/10/22 06:05  | 6/9/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 49 | 10.90 | 0 | 5 | 0 | 1,243 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/8/22 06:07  | 6/7/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 51 | 8.55 | 0 | 6 | 0 | 1,239 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/6/22 06:05  | 6/3/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 77 | 8.35 | 0 | 9 | 1 | 1,233 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/3/22 06:05  | 6/2/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 7.38 | 0 | 7 | 1 | 1,224 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/22/22 06:04  | 4/21/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 97 | 16.09 | 0 | 6 | 0 | 1,217 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/21/22 06:03  | 4/19/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 100 | 16.74 | 0 | 6 | 0 | 1,211 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/22 06:06  | 2/11/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 109 | 19.80 | 0 | 6 | 0 | 1,205 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/8/22 06:02  | 2/4/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 98 | 19.59 | 0 | 5 | 0 | 1,199 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/18/22 06:05  | 1/13/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 20 | 19.99 | 0 | 1 | 0 | 1,194 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/22 06:05  | 1/3/22  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 49 | 23.82 | 0 | 2 | 0 | 1,193 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/16/21 06:08  | 12/14/21  | GLSI | Greenwich Lifesciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DOT | CEO,CFO | P | 50 | 27.17 | 0 | 2 | 0 | 1,191 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/14/21 07:30  | 4/13/21  | GLSI | Greenwich Lifesciences, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 100 | 36.98 | 0 | 3 | 0 | 7,782 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/20/20 07:00  | 11/19/20  | GLSI | Greenwich Lifesciences, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 11 | 5.40 | 0 | 2 | 0 | 7,780 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/20 08:00  | 9/29/20  | GLSI | Greenwich Lifesciences, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 77 | 4.60 | 0 | 17 | 0 | 7,778 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/30/20 21:01  | 9/29/20  | GLSI | Greenwich Lifesciences, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | M.d | 0 | 0.00 | 0 | 1,665 | 36 | 6,353 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/29/20 21:42  | 9/29/20  | GLSI | Greenwich Lifesciences, Inc. | TX | Health | Drug | Pharmaceutical Preparations | Patel Snehal | TX | DO | CEO,CFO | P | 657 | 5.75 | 0 | 114 | 15 | 864 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |